Uma Exports Limited — Others, 15-11-2024: Copy of Newspaper Publication

Mangalam Drugs & Organics Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended September 30, 2024. The company reported a total income from operations of ₹799.43 crore, up from ₹765.36 crore year-on-year, while net profit for the period stood at ₹25.46 crore compared to a loss of ₹35.59 crore in the previous period. The improvement in profitability signals potential operational recovery, likely enhancing investor sentiment. However, the company must maintain this growth trajectory to mitigate previous losses and sustain a positive outlook.